Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 139.50
+5.00 (3.72%)
Sep 14, 2026, 2:02 PM CET
Oncoinvent ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 106.77 | 177.6 | 133.67 | 30.1 | 196.02 | 292.03 |
Cash & Short-Term Investments | 106.77 | 177.6 | 133.67 | 30.1 | 196.02 | 292.03 |
Cash Growth | 41.64% | 32.87% | 344.15% | -84.65% | -32.88% | 157.76% |
Accounts Receivable | 0.58 | 0.99 | 0.45 | - | - | - |
Other Receivables | 8.31 | 6.8 | 5.38 | 21.5 | 13.48 | 15.13 |
Receivables | 8.89 | 7.79 | 5.83 | 21.5 | 13.48 | 15.13 |
Prepaid Expenses | - | 1.92 | 2.78 | 4.3 | 3.21 | - |
Restricted Cash | - | - | - | 2.03 | - | - |
Other Current Assets | -0 | - | - | - | - | - |
Total Current Assets | 115.66 | 187.31 | 142.28 | 57.92 | 212.71 | 307.16 |
Property, Plant & Equipment | 10.51 | 15.58 | 26.71 | 40.81 | 21.45 | 10.34 |
Other Long-Term Assets | 2.07 | 2.07 | 2.03 | - | - | - |
Total Assets | 128.24 | 204.96 | 171.02 | 98.73 | 234.16 | 317.5 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.12 | 15.07 | 14.74 | 12.75 | 7.7 | 7.04 |
Accrued Expenses | 36.45 | 40.02 | 40.48 | 18.88 | 20.61 | 3.05 |
Current Portion of Leases | 2.04 | 2.88 | 2.71 | 3.83 | 3.19 | - |
Other Current Liabilities | -0 | -0 | 0 | - | - | 8.22 |
Total Current Liabilities | 47.6 | 57.96 | 57.94 | 35.46 | 31.5 | 18.31 |
Long-Term Leases | - | 0.68 | 4.74 | 8.35 | 8.84 | - |
Other Long-Term Liabilities | - | - | - | - | - | 0 |
Total Liabilities | 47.6 | 58.63 | 62.68 | 43.8 | 40.35 | 18.31 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.12 | 223.92 | 9.22 | 1.94 | 1.94 | 1.94 |
Additional Paid-In Capital | 43.95 | 43.95 | 726.28 | 538.15 | 537.65 | 537.4 |
Retained Earnings | 19.72 | -135.01 | -636.76 | -496.56 | -353.08 | -240.16 |
Comprehensive Income & Other | 15.85 | 13.47 | 9.6 | 11.39 | 7.31 | - |
Shareholders' Equity | 80.64 | 146.32 | 108.33 | 54.93 | 193.82 | 299.18 |
Total Liabilities & Equity | 128.24 | 204.96 | 171.02 | 98.73 | 234.16 | 317.5 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.04 | 3.55 | 7.45 | 12.17 | 12.03 | - |
Net Cash (Debt) | 104.74 | 174.05 | 126.22 | 17.92 | 183.99 | 292.03 |
Net Cash Growth | 51.42% | 37.90% | 604.25% | -90.26% | -37.00% | 157.76% |
Net Cash Per Share | 34.95 | 140.45 | 505.07 | 92.17 | 948.73 | 1469.46 |
Filing Date Shares Outstanding | 4.48 | 4.48 | 0.92 | 0.19 | 0.19 | 0.19 |
Total Common Shares Outstanding | 4.48 | 4.48 | 0.92 | 0.19 | 0.19 | 0.19 |
Working Capital | 68.06 | 129.35 | 84.34 | 22.47 | 181.21 | 288.85 |
Book Value Per Share | 18.01 | 32.67 | 117.44 | 282.50 | 999.42 | 1543.13 |
Tangible Book Value | 80.64 | 146.32 | 108.33 | 54.93 | 193.82 | 299.18 |
Tangible Book Value Per Share | 18.01 | 32.67 | 117.44 | 282.50 | 999.42 | 1543.13 |
Land | - | 34.02 | 34.02 | 33.12 | 13.24 | - |
Machinery | - | 28.33 | 28.21 | 28.07 | 21.11 | - |